Mechanism and Regulation of Nonhomologous DNA End Joining
非同源DNA末端连接的机制和调控
基本信息
- 批准号:8111276
- 负责人:
- 金额:$ 34.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-01 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgingBRCT DomainBindingCancer EtiologyCellsChemicalsChromosomal translocationChromosome PairingComplexDNADNA DamageDNA Double Strand BreakDNA RepairDNA Repair PathwayDNA SequenceDNA StructureDNA ligase IVDNA-PKcsDNA-Protein InteractionDevelopmentEnzymesFree RadicalsHistonesHumanIonizing radiationKu ProteinLengthLigaseLigationMalignant NeoplasmsMediatingModificationMutationNonhomologous DNA End JoiningPathway interactionsPolymerasePositioning AttributePriceProcessPropertyProteinsRadiationRadiation-Sensitizing AgentsRegulationSiteSomatic CellSystemTailTestingTherapeuticTimeVariantVertebral columnVertebratesWorkX-Ray CrystallographyXRCC4 geneartemischemotherapyflexibilityhomologous recombinationimprovedin vivoinhibitor/antagonistinorganic phosphateinsightmutantnucleasephosphodiesterpublic health relevancereconstitutionrepairedsmall moleculespatial relationshipstoichiometry
项目摘要
DESCRIPTION (provided by applicant): Double-strand DNA breaks (DSBs) occur in all cells multiple times per day. Homologous recombination (HR) and nonhomologous DNA end-joining (NHEJ) are the two primary pathways for repairing DSBs. However, NHEJ is the more general pathway because it does not require a homologous donor, and NHEJ is sufficiently flexible that it can join almost any pair of incompatible DNA ends. The flexibility of NHEJ is essential because natural causes of DSBs (ionizing radiation, free radicals, enzyme malfunction) generate DNA ends with diverse chemical and structural configurations. Hence, that flexibility is well-suited for the task, but the price that we pay for that flexibility is that NHEJ causes DNA sequence changes at most sites where it functions (in humans and other vertebrates). Hence, NHEJ generates somatic cell mutations that cause cancer and likely contribute to aging. The flexibility of NHEJ represents one of the most sophisticated protein:DNA interaction pathways. Though we know most of the proteins that participate in NHEJ and know, in broad terms, what they do, we do not have a clear picture of how they function together, their spatial configuration, or the temporal relationships. With a clearer mechanistic and structural picture of human NHEJ, we will be in a position to develop small molecule inhibitors that may be useful for treating cancer (as chemotherapy or as a radiation sensitizer). Aims 1 and 2 of this proposal focus precisely on the issues of structural and spatial relationships among the NHEJ proteins and with the DNA ends. Aim 3 tests the hypothesis that the NHEJ ligase complex is important for making key end-to-end contacts during NHEJ. Aim 4 describes development of a more robust NHEJ reconstitution. In Aim 4, that system is then used to identify any remaining NHEJ factors by testing for enhancement of activity. Aim 5 describes analysis of how histone octamers influence the nuclease, polymerase, and ligase activities of NHEJ. These studies will markedly improve our understanding of how NHEJ participates in processes such as chromosomal translocations that are of key importance in cancer etiology and how NHEJ might be made 'druggable' for therapeutic purposes.
PUBLIC HEALTH RELEVANCE: This project would clarify our insights into one of the key pathways for the repair of DNA damage. These insights will allow us to understand how some of the DNA damage that causes cancer and aging occurs. The benefits of some chemotherapy and therapeutic radiation work can be increased by this deeper level of understanding of this key DNA repair pathway.
描述(由申请方提供):所有细胞每天多次发生双链DNA断裂(DSB)。同源重组(HR)和非同源DNA末端连接(NHEJ)是DSB修复的两条主要途径。然而,NHEJ是更通用的途径,因为它不需要同源供体,并且NHEJ足够灵活,可以连接几乎任何一对不相容的DNA末端。NHEJ的灵活性是必不可少的,因为DSB的自然原因(电离辐射,自由基,酶故障)产生具有不同化学和结构构型的DNA末端。因此,这种灵活性非常适合这项任务,但我们为这种灵活性付出的代价是NHEJ在其发挥作用的大多数位点(在人类和其他脊椎动物中)引起DNA序列的变化。因此,NHEJ产生导致癌症的体细胞突变,并可能导致衰老。NHEJ的灵活性代表了最复杂的蛋白质:DNA相互作用途径之一。虽然我们知道大多数参与NHEJ的蛋白质,并且从广义上知道它们的作用,但我们并不清楚它们如何共同发挥作用,它们的空间结构或时间关系。随着人类NHEJ的更清晰的机制和结构图片,我们将能够开发可能用于治疗癌症的小分子抑制剂(作为化疗或放射增敏剂)。该提案的目标1和2恰恰关注NHEJ蛋白质之间以及与DNA末端之间的结构和空间关系问题。目的3测试NHEJ连接酶复合物对于在NHEJ期间进行关键的端对端接触是重要的假设。目的4描述了更稳健的NHEJ重构的开发。在目标4中,该系统然后用于通过测试活性的增强来识别任何剩余的NHEJ因子。目的5分析组蛋白八聚体如何影响NHEJ的核酸酶、聚合酶和连接酶活性。这些研究将显著提高我们对NHEJ如何参与癌症病因学中至关重要的染色体易位等过程以及NHEJ如何出于治疗目的而“可药用”的理解。
公共卫生相关性:该项目将阐明我们对DNA损伤修复的关键途径之一的见解。这些见解将使我们了解导致癌症和衰老的一些DNA损伤是如何发生的。一些化疗和放射治疗工作的好处可以通过对这一关键DNA修复途径的更深层次的理解来增加。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL R LIEBER其他文献
MICHAEL R LIEBER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL R LIEBER', 18)}}的其他基金
Mechanisms of Human Lymphoid Chromosomal Translocation
人类淋巴染色体易位的机制
- 批准号:
10219165 - 财政年份:2016
- 资助金额:
$ 34.47万 - 项目类别:
Mechanisms of Human Lymphoid Chromosomal Translocation
人类淋巴染色体易位的机制
- 批准号:
9756315 - 财政年份:2016
- 资助金额:
$ 34.47万 - 项目类别:
Mechanisms of Human Lymphoid Chromosomal Translocation
人类淋巴染色体易位的机制
- 批准号:
9099617 - 财政年份:2016
- 资助金额:
$ 34.47万 - 项目类别:
Site-Specific Recombination in Human Health & Disease
人类健康中的位点特异性重组
- 批准号:
10400938 - 财政年份:2016
- 资助金额:
$ 34.47万 - 项目类别:
Site-Specific Recombination in Human Health & Disease
人类健康中的位点特异性重组
- 批准号:
10162067 - 财政年份:2016
- 资助金额:
$ 34.47万 - 项目类别:
Site-Specific Recombination in Human Health & Disease
人类健康中的位点特异性重组
- 批准号:
10618161 - 财政年份:2016
- 资助金额:
$ 34.47万 - 项目类别:
Selective Inhibitors of the Artemis Endonuclease
Artemis 核酸内切酶的选择性抑制剂
- 批准号:
8420339 - 财政年份:2012
- 资助金额:
$ 34.47万 - 项目类别:
Selective Inhibitors of the Artemis Endonuclease
Artemis 核酸内切酶的选择性抑制剂
- 批准号:
8261909 - 财政年份:2012
- 资助金额:
$ 34.47万 - 项目类别:
Mechanism and Regulation of Nonhomologous DNA End Joining
非同源DNA末端连接的机制和调控
- 批准号:
8894424 - 财政年份:2003
- 资助金额:
$ 34.47万 - 项目类别:
MECHANISM AND REGULATION OF NONHOMOLOGOUS DNA ENDJOINING
DNA非同源连接的机制和调控
- 批准号:
6596588 - 财政年份:2003
- 资助金额:
$ 34.47万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 34.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 34.47万 - 项目类别:
Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 34.47万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 34.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 34.47万 - 项目类别:
Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 34.47万 - 项目类别:
Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 34.47万 - 项目类别:
Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 34.47万 - 项目类别:
Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
- 批准号:
23K20355 - 财政年份:2024
- 资助金额:
$ 34.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
- 批准号:
23K24782 - 财政年份:2024
- 资助金额:
$ 34.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)